These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14192530)

  • 1. THE EFFECT OF 6-AZAURIDINE ADMINISTRATION ON DE NOVO PYRIMIDINE PRODUCTION IN CHRONIC MYELOGENOUS LEUKEMIA.
    BONO VH; WEISSMAN SM; FREI E
    J Clin Invest; 1964 Jul; 43(7):1486-94. PubMed ID: 14192530
    [No Abstract]   [Full Text] [Related]  

  • 2. THE SENSITIVITY OF HUMAN LEUKAEMIAS TO 6-AZAURIDINE AND ITS RELATION TO URIDINE-KINASE ACTIVITY.
    WINKLER A; DRAHOVSKY D; GREGUSOVA V; SKUPENOVA A; HUPKA S; SKODA J; SORM F
    Acta Unio Int Contra Cancrum; 1964; 20():100-2. PubMed ID: 14151858
    [No Abstract]   [Full Text] [Related]  

  • 3. The biochemical activity of 6-azauridine: interference with pyrimidine metabolism in transplantable mouse tumors.
    PASTERNAK CA; HANDSCHUMACHER RE
    J Biol Chem; 1959 Nov; 234():2992-7. PubMed ID: 14430761
    [No Abstract]   [Full Text] [Related]  

  • 4. MITOTIC ABILITY OF LEUKEMIC LEUKOCYTES IN CHRONIC MYELOCYTIC LEUKEMIA.
    SANDBERG AA; KIKUCHI Y; CROSSWHITE LH
    Cancer Res; 1964 Sep; 24():1468-73. PubMed ID: 14221804
    [No Abstract]   [Full Text] [Related]  

  • 5. HYPOCHOLESTEROLAEMIA AND OROTIC ACIDURIA DURING TREATMENT WITH 6-AZAURIDINE.
    BUTTOO AS; ISRAUELS MC; WILKINSON JF
    Br Med J; 1965 Feb; 1(5434):552-4. PubMed ID: 14243057
    [No Abstract]   [Full Text] [Related]  

  • 6. THE EFFECT OF TREATMENT IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA. BIOCHEMICAL STUDIES.
    BLOCK JB; CARBONE PP; OPPENHEIM JJ; FREI E
    Ann Intern Med; 1963 Nov; 59():629-36. PubMed ID: 14082716
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations in pyrimidine metabolism in L5178Y leukemia cells resistant to 6-azauridine.
    PASTERNAK CA; FISCHER GA; HANDSCHUMACHER RE
    Cancer Res; 1961 Jan; 21():110-7. PubMed ID: 13733201
    [No Abstract]   [Full Text] [Related]  

  • 8. STUDIES OF PYRIMIDINE NUCLEOTIDE METABOLISM IN THE CENTRAL NERVOUS SYSTEM-I. METABOLIC EFFECTS AND METABOLISM OF 6-AZAURIDINE.
    WELLS W; GAINES D; KOENIG H
    J Neurochem; 1963 Oct; 10():709-23. PubMed ID: 14087684
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic myelogenous leukemia.
    BOONE DW
    J Osteopath (Kirksvill); 1953 Jan; 60(1):21-3. PubMed ID: 13023499
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neoplastic changes during the course of chronic myelocytic leukemia].
    JUDKIEWICZ L; KRYKOWSKI E; MIODUSZEWSKA O
    Pol Arch Med Wewn; 1962; 32():707-8. PubMed ID: 13957968
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of extremely long survival in chronic myelogenous leukemia.
    VAN DER WERFF JT
    Br J Radiol; 1952 Jan; 25(289):52-3. PubMed ID: 14895910
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bone marrow hematopoiesis in patients with chronic myelosis before and after treatment with myleran].
    VAKULENKO AD
    Probl Gematol Pereliv Krovi; 1959 Nov; 4():58-60. PubMed ID: 13840740
    [No Abstract]   [Full Text] [Related]  

  • 13. [A CASE OF HYPOGAMMAGLOBULINEMIA IN CHRONIC ALEUKEMIC MYELOCYTIC LEUKEMIA].
    KUSKA J; KOKOT F
    Pol Tyg Lek; 1964 Jun; 19():1007-8. PubMed ID: 14207987
    [No Abstract]   [Full Text] [Related]  

  • 14. [SUPPORTIVE THERAPY IN CHRONIC MYELOCYTIC LEUKEMIA].
    BALGOZHINA ShZh
    Sov Med; 1964 Nov; 27():3-8. PubMed ID: 14311420
    [No Abstract]   [Full Text] [Related]  

  • 15. [CHRONIC MYELOCYTIC LEUKEMIA. RESULTS OF TREATMENT FROM 1954 TO 1963].
    WARTLICK V; MARTIN H
    Ther Ggw; 1964 Oct; 103():1299-308. PubMed ID: 14319047
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of 2, 4-diamino-5-p-chlorophenyl-6-ethyl-pirimidine on chronic myelocytic leukemia].
    GIGANTE D; ZOPPINI A
    Gazz Med Ital; 1956 Apr; 115(4):95-9. PubMed ID: 13344889
    [No Abstract]   [Full Text] [Related]  

  • 17. [Casuistics on myleran treatment in chronic myelocytic leukemia].
    KOSENOW W
    Arch Kinderheilkd; 1956; 153(3):251-4. PubMed ID: 13355417
    [No Abstract]   [Full Text] [Related]  

  • 18. BIOSYNTHESIS OF HEME AND STERCOBILIN IN CHRONIC MYELOID LEUKEMIA AND IRON DEFICIENCY ANEMIA. STUDY WITH 2-14C-GLYCINE.
    FUJII M
    Nihon Ketsueki Gakkai Zasshi; 1964 Oct; 27():529-43. PubMed ID: 14280085
    [No Abstract]   [Full Text] [Related]  

  • 19. The plasma disappearance, excretion, and tissue distribution of cobalt 60 labelled vitamin B12 in normal subjects and patients with chronic myelogenous leukemia.
    CORBUS HF; MILLER A; SULLIVAN JF
    J Clin Invest; 1957 Jan; 36(1 Part 1):18-24. PubMed ID: 13398478
    [No Abstract]   [Full Text] [Related]  

  • 20. STEROID HORMONE METABOLISM IN CHRONIC MYELOGENOUS LEUKEMIA.
    GALLAGHER TF; HELLMAN L; ZUMOFF B; MILLER DG
    Blood; 1965 May; 25():743-8. PubMed ID: 14282043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.